- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on COVID-19 Infection in Hematological Malignancies Patients in South Africa
Total 308 results
-
GlaxoSmithKlineCompletedCOVID-19 | SARS-CoV-2Australia, United States, Philippines
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, Belgium, France, Spain, United Kingdom
-
The George InstituteCompletedCOVID-19 | Coronavirus Disease 2019Australia, India
-
Population Health Research InstituteBayerCompletedSevere Acute Respiratory Syndrome | CoronavirusEgypt, Canada, Brazil, Colombia, Ecuador, India, Nepal, Pakistan, Philippines, Russian Federation, South Africa, United Arab Emirates
-
Gilead SciencesTerminatedCOVID-19United States, Spain, Denmark, United Kingdom
-
Revive Therapeutics, Ltd.Terminated
-
PfizerCompleted
-
GlaxoSmithKlineRecruitingRespiratory Syncytial Virus InfectionsUnited States, Belgium, Netherlands, Spain
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, United Kingdom
-
NovavaxActive, not recruiting
-
Regeneron PharmaceuticalsTerminated
-
AstraZenecaIqvia Pty LtdCompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19 | SARS-CoV-2United States, Chile, Peru
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Korea, Republic of
-
Blade TherapeuticsClinipace WorldwideCompletedCovid19 | Sars-CoV-2United States, Brazil
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Regeneron PharmaceuticalsCompleted
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; University... and other collaboratorsCompletedCOVID-19United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca; University of... and other collaboratorsActive, not recruitingCOVID-19United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Invivyd, Inc.TerminatedCOVID-19United States, Argentina, Czechia, Georgia, Germany, Moldova, Republic of, Poland, Romania, Ukraine
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
PfizerCompletedCOVID-19United States, Taiwan, Italy, Canada, Greece
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
Daniel BenjaminNational Center for Advancing Translational Sciences (NCATS); Biomedical Advanced...CompletedCovid19United States, Brazil, Argentina, Mexico, Peru
-
National Institute of Allergy and Infectious Diseases...Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaboratorsCompletedCovid19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...CompletedCOVID-19United States, Puerto Rico, Argentina
-
BioNTech SEPfizerRecruiting
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
ModernaTX, Inc.Active, not recruitingCOVID-19United States, United Kingdom, Canada
-
Erasmus Medical CenterLeiden University Medical Center; Medical Center Haaglanden; Rijnstate Hospital; Maasstadziekenhu... and other collaboratorsRecruitingHIV Infections | Acquired Immunodeficiency Syndrome | Sexually Transmitted Diseases, Viral | Pneumonia | Psoriasis | Weight Loss | Thrombocytopenia | Leukopenia | Dermatitis, Seborrheic | Herpes Zoster | Lymphadenopathy | Uterine Cervical Dysplasia | Primary Health Care | Diarrhea Chronic | Candida Infection | Infectious... and other conditionsNetherlands
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences; University... and other collaboratorsCompleted
-
BiotestRecruitingCOVID-19 | Pneumonia | Acute Respiratory Distress Syndrome | Community-acquired Pneumonia | Respiratory Infection | Bacterial Pneumonia | Viral Pneumonia | Fungal PneumoniaBelgium, Brazil, Latvia, Germany, Lithuania, South Africa, Argentina, Austria, France, Hungary, Slovakia, Turkey, Portugal, Spain
-
QuantumLeap Healthcare CollaborativeM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pennsylvania and other collaboratorsRecruitingCOVID-19United States
-
Alexion PharmaceuticalsTerminatedPneumonia, Viral | Acute Respiratory Distress Syndrome | Acute Lung Injury | COVID-19 Severe PneumoniaUnited States, Spain, United Kingdom, France, Japan
-
Cynata Therapeutics LimitedCerebral Palsy AllianceCompletedCovid19 | Acute Respiratory Distress SyndromeAustralia
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
Thomas L. OrtelNational Heart, Lung, and Blood Institute (NHLBI)Completed